» Articles » PMID: 17485645

Rate, Degree, and Predictors of Recovery from Disability Following Ischemic Stroke

Overview
Journal Neurology
Specialty Neurology
Date 2007 May 9
PMID 17485645
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the rate, degree, and predictors of recovery from disabling ischemic stroke.

Methods: Patients with ischemic stroke enrolled in the Management of Atherothrombosis With Clopidogrel in High-Risk Patients (MATCH) study underwent long-term prospective assessment of their modified Rankin Scale (mRS) score. Disability (functionally dependent state) was defined as mRS > or = 3, and recovery (functionally independent state) was defined as mRS < 3. The timing and the independent predictors of recovery were determined using a Cox proportional hazards multiple regression analysis.

Results: Of 7,599 patients enrolled with ischemic stroke or TIA, 1,662 (21.8%) were disabled (mRS > or = 3) at baseline (median of 14 [0 to 96] days after stroke onset). Disability was moderate (mRS 3) in 931 (56%) patients, severe (mRS 4) in 691 (42%), and very severe (mRS 5) in 40 (2%). By 18 months, 877 (52.8%, 95% CI 50% to 55%) patients had recovered, 589 (63%, 60% to 66%) with moderate disability, 281 (41%, 37% to 44%) with severe disability, and 7 (17%, 7 to 33%) with very severe disability. Median time to recovery was 3 months for patients with moderate disability and 18 months for severe disability; 82.5% of severely disabled patients remained so at 18 months. Predictors of recovery were moderate disability (mRS 3) at baseline compared with severe (mRS 4: hazard ratio [HR] 2.13, 1.86 to 2.44) or very severe disabling stroke (HR 5.88, 2.86 to 12.5); younger women (aged <65 years, compared with > or =75 years; HR 1.85, 1.47 to 2.33); decreasing time (days) between the qualifying event and the baseline assessment (HR 1.01, 1.01 to 1.02); and the absence of previous ischemic stroke (HR 1.61, 1.35 to 1.92), concurrent peripheral artery disease (HR 1.61, 1.23 to 2.13), or diabetes (HR 1.30, 1.10 to 1.54).

Conclusions: Half of patients with disabling ischemic stroke recovered within 18 months, and recovery was greatest within 6 months. Significant predictors of recovery included the severity of the index stroke and no history of ischemic stroke, peripheral artery disease, or diabetes.

Citing Articles

Molecular Targeting of Ischemic Stroke: The Promise of Naïve and Engineered Extracellular Vesicles.

Lee J, Geum D, Park D, Kim J Pharmaceutics. 2025; 16(12.

PMID: 39771472 PMC: 11678501. DOI: 10.3390/pharmaceutics16121492.


What the National Coverage Determination for Carotid Artery Stenting Means for the Treatment of Patients with Carotid Artery Disease.

Hicks C, Veith F Ann Vasc Surg. 2024; 113:337-345.

PMID: 39374802 PMC: 11903182. DOI: 10.1016/j.avsg.2024.09.037.


Cost-effectiveness of tirofiban for acute ischemic stroke without large or medium-sized vessel occlusion: A Markov modelling analysis from the Chinese and United States perspectives.

Wang L, Zeng Y, Zhou L, Xu P, Guo X, Xie Y PLoS One. 2024; 19(2):e0297939.

PMID: 38363737 PMC: 10871502. DOI: 10.1371/journal.pone.0297939.


One-Year Disability Trajectories and Long-Term Cardiovascular Events, Recurrent Stroke, and Mortality After Ischemic Stroke.

Du J, Zhai Y, Dong W, Che B, Miao M, Peng Y J Am Heart Assoc. 2024; 13(3):e030702.

PMID: 38240201 PMC: 11056157. DOI: 10.1161/JAHA.123.030702.


Post-Stroke Brain Health Monitoring and Optimization: A Narrative Review.

Stulberg E, Sachdev P, Murray A, Cramer S, Sorond F, Lakshminarayan K J Clin Med. 2023; 12(23).

PMID: 38068464 PMC: 10706919. DOI: 10.3390/jcm12237413.